Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOST
NCT07094711Phase 2Recruiting
- Sponsor
- University of Virginia
- Start
- Apr 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Mycobacterium avium complex lung disease (2 arms), sponsored by University of Virginia. Primary endpoints: Adverse Events at 12 weeks, Serious Adverse Events at 12 months and 1 more. Started Apr 2026; status: recruiting.
02
Conditions
Mycobacterium avium complex lung disease
Beyond the preview
Go deeper on NCT07094711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07094711.